These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 4062970)
21. Nucleoside transport in rat cerebral-cortical synaptosomes. Evidence for two types of nucleoside transporters. Lee CW; Jarvis SM Biochem J; 1988 Jan; 249(2):557-64. PubMed ID: 3342028 [TBL] [Abstract][Full Text] [Related]
22. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep. SenGupta DJ; Unadkat JD Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197 [TBL] [Abstract][Full Text] [Related]
23. Induction of nucleoside transport sites into the host cell membrane of Babesia bovis infected erythrocytes. Gero AM Mol Biochem Parasitol; 1989 Jul; 35(3):269-76. PubMed ID: 2747745 [TBL] [Abstract][Full Text] [Related]
24. Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors. el Kouni MH; Messier NJ; Cha S Biochem Pharmacol; 1987 Nov; 36(22):3815-21. PubMed ID: 3689423 [TBL] [Abstract][Full Text] [Related]
25. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation. Liu Y; Cone J; Le SN; Fong M; Tao L; Shoaf SE; Bricmont P; Czerwiec FS; Kambayashi J; Yoshitake M; Sun B J Cardiovasc Pharmacol; 2004 Aug; 44(2):266-73. PubMed ID: 15243309 [TBL] [Abstract][Full Text] [Related]
26. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. Yao SY; Ng AM; Muzyka WR; Griffiths M; Cass CE; Baldwin SA; Young JD J Biol Chem; 1997 Nov; 272(45):28423-30. PubMed ID: 9353301 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of rapidly accumulated adenosine by dissociated brain cells from adult rat. Geiger JD; Johnston ME; Yago V J Neurochem; 1988 Jul; 51(1):283-91. PubMed ID: 3379409 [TBL] [Abstract][Full Text] [Related]
28. Species differences in the binding of [3H]nitrobenzylthioinosine to the nucleoside transport system in mammalian central nervous system membranes: evidence for interconvertible conformations of the binding site/transporter complex. Hammond JR; Clanachan AS J Neurochem; 1985 Aug; 45(2):527-35. PubMed ID: 4009173 [TBL] [Abstract][Full Text] [Related]
29. Differential effects of the pyrimido-pyrimidine derivatives, dipyridamole and mopidamol, on platelet and vascular cyclooxygenase activity. De La Cruz JP; Ortega G; Sánchez de la Cuesta F Biochem Pharmacol; 1994 Jan; 47(2):209-15. PubMed ID: 8304965 [TBL] [Abstract][Full Text] [Related]
30. The kinetics of dissociation of the inhibitor of nucleoside transport, nitrobenzylthioinosine, from the high-affinity binding sites of cultured hamster cells. Koren R; Cass CE; Paterson AR Biochem J; 1983 Nov; 216(2):299-308. PubMed ID: 6661198 [TBL] [Abstract][Full Text] [Related]
31. Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity. Paproski RJ; Visser F; Zhang J; Tackaberry T; Damaraju V; Baldwin SA; Young JD; Cass CE Biochem J; 2008 Sep; 414(2):291-300. PubMed ID: 18462193 [TBL] [Abstract][Full Text] [Related]
32. Calcium entry blocking activity of dilazep in dog coronary artery. Nakagawa Y; Gudenzi M; Mustafa SJ Pharmacology; 1986; 33(3):148-56. PubMed ID: 3018802 [TBL] [Abstract][Full Text] [Related]
33. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity. Gresele P; Arnout J; Deckmyn H; Vermylen J Thromb Haemost; 1986 Feb; 55(1):12-8. PubMed ID: 3704998 [TBL] [Abstract][Full Text] [Related]
34. Nucleoside transport in heart: species differences in nitrobenzylthioinosine binding, adenosine accumulation, and drug-induced potentiation of adenosine action. Williams EF; Barker PH; Clanachan AS Can J Physiol Pharmacol; 1984 Jan; 62(1):31-7. PubMed ID: 6713281 [TBL] [Abstract][Full Text] [Related]
35. A comparative study on the effect of dilazep and dipyridamole on some platelet functions. Valori VM; Leone G; Traisci G; Bizzi B Arzneimittelforschung; 1982; 32(4):403-5. PubMed ID: 7201810 [TBL] [Abstract][Full Text] [Related]
37. Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole. Visser F; Vickers MF; Ng AM; Baldwin SA; Young JD; Cass CE J Biol Chem; 2002 Jan; 277(1):395-401. PubMed ID: 11689555 [TBL] [Abstract][Full Text] [Related]
38. [3H]dipyridamole binding to nucleoside transporters from guinea-pig and rat lung. Shi MM; Young JD Biochem J; 1986 Dec; 240(3):879-83. PubMed ID: 3827876 [TBL] [Abstract][Full Text] [Related]
39. Interaction of [3H]dilazep at nucleoside transporter-associated binding sites on S49 mouse lymphoma cells. Gati WP; Paterson AR Mol Pharmacol; 1989 Jul; 36(1):134-41. PubMed ID: 2747624 [TBL] [Abstract][Full Text] [Related]
40. Metabolism of adenosine analogues by Schistosoma mansoni and the effect of nucleoside transport inhibitors. el Kouni MH; Cha S Biochem Pharmacol; 1987 Apr; 36(7):1099-106. PubMed ID: 3566804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]